Download
1476-4598-12-4.pdf 2,56MB
WeightNameValue
1000 Titel
  • Inhibition of clathrin by pitstop 2 activates the spindle assembly checkpoint and induces cell death in dividing HeLa cancer cells
1000 Autor/in
  1. Smith, Charlotte M. |
  2. McCluskey, Adam |
  3. Robinson, Phillip J. |
  4. Chircop, Megan |
  5. Haucke, Volker |
1000 Erscheinungsjahr 2013
1000 LeibnizOpen
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2013-01-17
1000 Erschienen in
1000 Quellenangabe
  • 12: 4
1000 FRL-Sammlung
1000 Copyrightjahr
  • 2013
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/1476-4598-12-4 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567983/ |
1000 Ergänzendes Material
  • https://molecular-cancer.biomedcentral.com/articles/10.1186/1476-4598-12-4#Declarations |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • BACKGROUND: During metaphase clathrin stabilises the mitotic spindle kinetochore(K)-fibres. Many anti-mitotic compounds target microtubule dynamics. Pitstop 2™ is the first small molecule inhibitor of clathrin terminal domain and inhibits clathrin-mediated endocytosis. We investigated its effects on a second function for clathrin in mitosis. RESULTS: Pitstop 2 did not impair clathrin recruitment to the spindle but disrupted its function once stationed there. Pitstop 2 trapped HeLa cells in metaphase through loss of mitotic spindle integrity and activation of the spindle assembly checkpoint, phenocopying clathrin depletion and aurora A kinase inhibition. CONCLUSIONS: Pitstop 2 is therefore a new tool for investigating clathrin spindle dynamics. Pitstop 2 reduced viability in dividing HeLa cells, without affecting dividing non-cancerous NIH3T3 cells, suggesting that clathrin is a possible novel anti-mitotic drug target.
1000 Sacherschließung
lokal Cancer
lokal Cell death
lokal Metaphase
lokal Pitstop
lokal Spindle assembly checkpoint
lokal Clathrin
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/creator/U21pdGgsIENoYXJsb3R0ZcKgTS4=|https://frl.publisso.de/adhoc/creator/TWNDbHVza2V5LCBBZGFt|https://frl.publisso.de/adhoc/creator/Um9iaW5zb24sIFBoaWxsaXDCoEou|https://frl.publisso.de/adhoc/creator/Q2hpcmNvcCwgTWVnYW4=|http://orcid.org/0000-0003-3119-6993
1000 Label
1000 Förderer
  1. National Health and Medical Research Council (NH&MRC) of Australia |
  2. Deutsche Forschungsgemeinschaft (DFG) |
1000 Fördernummer
  1. -
  2. SFB765/B4; FOR806-HA2686/3-2
1000 Förderprogramm
  1. Career Development Award Fellowship
  2. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer National Health and Medical Research Council (NH&MRC) of Australia |
    1000 Förderprogramm Career Development Award Fellowship
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer Deutsche Forschungsgemeinschaft (DFG) |
    1000 Förderprogramm -
    1000 Fördernummer SFB765/B4; FOR806-HA2686/3-2
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6404626.rdf
1000 Erstellt am 2017-09-25T09:44:06.418+0200
1000 Erstellt von 218
1000 beschreibt frl:6404626
1000 Bearbeitet von 288
1000 Zuletzt bearbeitet 2022-08-18T07:52:44.055+0200
1000 Objekt bearb. Thu Mar 04 12:03:14 CET 2021
1000 Vgl. frl:6404626
1000 Oai Id
  1. oai:frl.publisso.de:frl:6404626 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source